Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture to Treat Cartilage Defects of the Knee (N3D)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Tetec AG
Sponsor:
Information provided by (Responsible Party):
Tetec AG
ClinicalTrials.gov Identifier:
NCT01656902
First received: July 20, 2012
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2020
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)